-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$11.67190.3% Upside
Ironwood Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Ironwood Pharmaceuticals, Inc.?
Ironwood Pharmaceuticals, Inc. has been rated by research analysts at Leerink Partners, Wells Fargo, Piper Sandler in the past 90 days.